India-backed COVID-19 vaccine is expected to be launched as early as February 2021, Reuters report.
At the last stages of its trials Indian scientists confirmed so far the virus is safe and effective, Bharat Biotech with the support of the Indian Council of Medical Research is developing COVAXIN.
“The vaccine has shown good efficacy,” senior ICMR scientist Rajni Kant told Reuters, adding “It is expected that by the beginning of next year, February or March, something would be available.”
Rajni Kant who is also the head of ICMR’s research management, policy, planning, and coordination cell hinted it is up to the Indian health ministry to decide if shots can be given to the public before the third stage.
Kant stressed, that “It has shown safety and efficacy in phase 1 and 2 trials and in the animal studies – so it is safe but you can’t be 100% sure unless the phase 3 trials are over, there may be some risk, if you are ready to take the risk, you can take the vaccine. If necessary, the government can think of giving the vaccine in an emergency situation”.
COAXIN development head, allows the government to give the vaccine in emergency situations.
Indian government considered granting initial emergency authorization for the vaccine shot to be given to the elderly and people in high-work places.
AstraZeneca a company that announced to release their version of vaccine by early December also signed a deal with Serum Institute of India.
meanwhile, Germany announced their coronavirus cases increased by 19,990 to 596,583, new lock downs announced, as people rushed for stockpiles